Risultati della ricerca - Agnes Witkiewicz

  • Mostra 1 - 5 risultati su 5
Raffina i risultati
  1. 1
    RB-pathway disruption in breast cancer

    RB-pathway disruption in breast cancer di Adam Ertel, Jeffry L. Dean, Hallgeir Rui, Chengbao Liu, Agnes Witkiewicz, Karen E. Knudsen, Erik S. Knudsen

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

    Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells di Christine L. Hostetter, Lauren A. Licata, Christina L. Costantino, Agnes Witkiewicz, Charles Yeo, Jonathan R. Brody, Judith C. Keen

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth

    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth di Kongming Wu, Sanjay Katiyar, Agnes Witkiewicz, Anping Li, Peter A. McCue, Liang‐Nian Song, Lifeng Tian, Ming Jin, Richard G. Pestell

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward?

    Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward? di Shayna L. Showalter, Timothy N. Showalter, Agnes Witkiewicz, Robert I. Havens, Eugene P. Kennedy, Tomáš Hucl, Scott E. Kern, Charles J. Yeo, Jonathan R. Brody

    Pubblicazione 2008
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

    Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer di Lyndsay N. Harris, Fanglei You, Stuart J. Schnitt, Agnes Witkiewicz, Xin Lü, Dennis C. Sgroi, Paula D. Ryan, Steven E. Come, Harold J. Burstein, Beth-Ann Lesnikoski, Madhavi Kamma, Paula N. Friedman, Rebecca Gelman, J. Dirk Iglehart, Eric P. Winer

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: